Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
Go back to Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update| Labranche & Co (NASDAQ: LAB) | Delayed: 0.89 +0.03 (3.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.86 | 52 Week High | $4.47 | |||
| Open | $0.85 | 52 Week Low | $3.02 | |||
| Day High | $0.91 | P/E | N/A | |||
| Day Low | $0.85 | EPS | $-1.56 | |||
| Volume | 958,500 | |||||

